GreenLight SPAC Presentation Deck slide image

GreenLight SPAC Presentation Deck

Enabled by our platform, we will pursue a mix of collaborations and branded products Cost-effective production can open up numerous categories of GreenLight products and collaborations GreenLight's cell-free platform Markets Categories Products Agriculture and Food Production Cost, scale, stability, speed, quality dsRNA The ability to suppress protein synthesis Insecticide $17 bn5 Fungicide $16.5 bn5 Biomolecules, including sweeteners Agriculture company partnerships Food company partnerships (1) World Health Organization and MI4A, "Global Vaccine Market Report," (2020) (2) Fortune Business Insights, "Vaccines Market to Touch USD 105.87B by 2027," (2020) (3) Fortune Business Insights, "Monoclonal Antibody Market to Reach USD 350B by 2027," (2020) Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. Human Health Scale, speed, modularity mRNA The instructions to make proteins Vaccines 2019: $33B1¹ 2020: $93B² Gene therapies 2021: $3.4B4 Pharma company partnerships (4) Grandview Research: "Gene Therapy Market Size, Share & Trends Analysis Report, 2021-2028" (5) AgBiolnvestor - AgBioSelect Database 12
View entire presentation